Assessment of meibomian gland dysfunction and dry eye disease by using novel noninvasive ocular surface analyzer in people with type 2 diabetes
Journal of Diabetology · 2024
DOI: 10.4103/jod.jod_101_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetology, 2024. Verfasst von Sharjeel Sultan und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
To assess meibomian gland dysfunction (MGD) and dry eye disease in people with type 2 diabetes using a novel noninvasive ocular surface analyzer. Materials and Methods: This prospective study was conducted in the Ophthalmology Department, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, from June to December 2020. MGD is defined as increased lipids and proteins in the meibomian glands, leading to increased severity of dry eye disease symptoms. People with type 2 diabetes underwent an ocular surface examination; lipid layer thickness, noninvasive breakup time, tear meniscus height, grading of meibomian gland loss, and expression of meibum by a noninvasive analyzer. MGD was graded based on minimal to mild, moderate, and marked symptoms and divided into four subtypes.
Result
A total of 46 diabetic subjects, 24 (52.2%) were males and 22 (47.8%) were females, with a median age of 55 (50–67.5) and 48 (41.5–55.25) years. Most of the subjects had mild gland opening for both the right and the left eye (50% and 54.3%). MGD score 1 was found in 12 (26.7%) and 11 (24.4%) subjects for the right and the left eye, respectively. Score 2 was observed mostly in the right eye 32 (71.1%) while score 3 was more frequent in the left eye 27 (60%). Notably, the conjunctival and ciliary levels were predominantly normal.
Conclusion
Most of the participants had moderate to severe loss of the meibomian gland in both eyes.
Zitieren
APA
Sultan, S., Butt, A., Shakeel, A., Khanzada, M. A., Fawwad, A., & Basit, A. (2024). Assessment of meibomian gland dysfunction and dry eye disease by using novel noninvasive ocular surface analyzer in people with type 2 diabetes. Journal of Diabetology. https://doi.org/10.4103/jod.jod_101_23
Vancouver
Sultan S, Butt A, Shakeel A, Khanzada MA, Fawwad A, Basit A. Assessment of meibomian gland dysfunction and dry eye disease by using novel noninvasive ocular surface analyzer in people with type 2 diabetes. Journal of Diabetology. 2024. doi:10.4103/jod.jod_101_23
BibTeX
@article{Sultan2024,
author = {Sultan, Sharjeel and Butt, Anum and Shakeel, Ayisha and Khanzada, Mahtab A. and Fawwad, Asher and Basit, Abdul},
title = {Assessment of meibomian gland dysfunction and dry eye disease by using novel noninvasive ocular surface analyzer in people with type 2 diabetes},
journal = {Journal of Diabetology},
year = {2024},
doi = {10.4103/jod.jod_101_23}
}
EUVIMED